Compounds > rolipram
Page last updated: 2024-11-04

rolipram and Adenoma, Basal Cell

rolipram has been researched along with Adenoma, Basal Cell in 1 studies

Research Excerpts

ExcerptRelevanceReference

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gordeladze, JO1

Other Studies

1 other study available for rolipram and Adenoma, Basal Cell

ArticleYear
The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.
    Bioscience reports, 1990, Volume: 10, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenoma; Adenylyl Cyclases; Animals; Colforsin; Cyclic AMP; Enz

1990